70 filings
IRAN
NVO
Novo Nordisk
31 Jan 24
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
6:55am
UPLOAD
NVO
Novo Nordisk
1 Dec 23
Letter from SEC
12:00am
CORRESP
NVO
Novo Nordisk
24 Nov 23
Correspondence with SEC
12:00am
CORRESP
NVO
Novo Nordisk
9 Nov 23
Correspondence with SEC
12:00am
UPLOAD
NVO
Novo Nordisk
3 Nov 23
Letter from SEC
12:00am
CORRESP
ubck2x
20 Oct 23
Correspondence with SEC
12:00am
CORRESP
d3bl0p f7x0flj
29 Sep 23
Correspondence with SEC
12:00am
UPLOAD
bnkftcpadug
27 Sep 23
Letter from SEC
12:00am
EFFECT
rjaa co960l
14 Sep 23
Notice of effectiveness
12:15am
CORRESP
0i5raqz q43db7
13 Sep 23
Correspondence with SEC
12:00am
CORRESP
0t9qduj7
5 Sep 23
Correspondence with SEC
12:00am
UPLOAD
8jw8ef1xi4nxvu3l
31 Aug 23
Letter from SEC
12:00am
SD
79qxg6tuf cx
23 May 23
Conflict minerals disclosure
8:09am
IRAN
bol8ieh
1 Feb 23
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
7:58am
SD
vqzxbhe pld4apkof
31 May 22
Conflict minerals disclosure
9:07am
IRAN
48y0ynhh
2 Feb 22
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
9:13am
SD
io056mp kip
27 May 21
Conflict minerals disclosure
10:46am
IRAN
arq0 5cdv2
3 Feb 21
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
2:36pm
SD
o4inhdlw
28 May 20
Conflict minerals disclosure
11:11am
IRAN
fpufc2crn1o97 5wr
5 Feb 20
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
9:44am